Nuvve Holding Corp. Earnings Per Share Disclosure
| Years Ended December 31, | ||||||||||||||
| 2024 | 2023 | |||||||||||||
| Net loss attributable to Nuvve Holding Corp. common stockholders | $ | (17,397,603) | $ | (32,215,790) | ||||||||||
| Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted | 646,329 | 79,827 | ||||||||||||
| Net loss per share attributable to Nuvve common stockholders, basic and diluted | $ | (26.92) | $ | (403.57) | ||||||||||
| Years Ended December 31, | ||||||||||||||
| 2024 | 2023 | |||||||||||||
| Stock options issued and outstanding | 1,916 | 6,906 | ||||||||||||
| Nonvested restricted stock issued and outstanding | 4,743 | 1,117 | ||||||||||||
| Public warrants | 7,188 | 7,188 | ||||||||||||
| Private warrants | 341 | 341 | ||||||||||||
| PIPE warrants | 3,384 | 3,384 | ||||||||||||
| Stonepeak and Evolve warrants | — | 15,000 | ||||||||||||
| Stonepeak and Evolve options | — | 12,500 | ||||||||||||
| Institutional/Accredited Investor Pre-Funded Warrants | — | 11,267 | ||||||||||||
| Institutional/Accredited Investor Warrants | 10,000 | 10,000 | ||||||||||||
| Underwriter Warrant - February 2024 offering | 25,500 | — | ||||||||||||
| 2024 February Institutional/Accredited Investor Warrants - series A | 480,000 | — | ||||||||||||
| 2024 February Institutional/Accredited Investor Warrants - series C | 30,000 | — | ||||||||||||
| 2024 October Institutional/Accredited Investor Warrants | 1,102,295 | — | ||||||||||||
| 2024 December Institutional/Accredited Investor Warrants | 85,287 | — | ||||||||||||
| Total | 1,750,654 | 67,703 | ||||||||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.